Covexin 10
国: アイルランド
言語: 英語
ソース: HMA (Heads of Medicines Agencies)
製品の特徴
(SPC)
21-08-2013
この製品の一部のドキュメントは現在利用できません。カスタマーサービスにリクエストを送信できます。入手可能になり次第、お知らせします。
リクエストを送信します。
リクエストを送信します。
有効成分:
C. chauvoei whole culture 0 , C. novyi Type B toxcid 0 , C. perfringens Type A Toxcid 0 ml, C. perfringens Type B & C toxcid 0 ml, C. perfringens Type D toxcid 0 ml, C. septicum toxcid 0 , C. sordellii toxcid 0 , C. tetani toxcid 0
から入手可能:
Schering-Plough Limited
ATCコード:
QI02AB01
医薬品形態:
Suspension for injection
治療領域:
Cattle, Sheep
承認日:
2011-03-11
製品の特徴
Revised: June 2013
AN: 00069/2013
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Covexin 10 Suspension for Injection for Sheep and Cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredients
Potency value/mL
_C. perfringens_ type A toxoid
0.5 U
#
_ _
_C. perfringens _type B & C (
β)
toxoid
18.2 IU*
_C. perfringens_ type D (
ε) toxoid
5.3 IU*
_C. chauvoei_ whole culture
meets Ph Eur.**
_C. novyi_ toxoid
3.8 IU*
_C. septicum_ toxoid
4.6 IU*
_C. tetani_ toxoid
4.9 IU*
_C_._ sordellii_ toxoid
4.4 U
1
_C. haemolyticum_ Toxoid
17.4 U
#
_Adjuvant _
Alum
3.03
– 4.09 mg/mL Aluminium
Preservative
_ _
Thiomersal
0.05
– 0.18 mg/mL
Excipient to 1 ml
_ _
Formaldehyde
0.5mg/mL_ _
_ _
* ELISA According to Ph.Eur
** Challenge test according to Ph.Eur.
1
In House ELISA
#
In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection
Light brown aqueous suspension that settles on storage
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep and cattle
Revised: June 2013
AN: 00069/2013
Page 2 of 6
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of sheep and cattle against diseases associated with
infections caused by _Clostridium perfringens_ type A, _C. perfringens _type B, _C. _
_perfringens_ type C, _C. perfringe
完全なドキュメントを読む
